当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2012年第36期 > 正文
编号:12352707
血清CXC趋化因子配体16水平与冠心病的(3)
http://www.100md.com 2012年12月25日 陈秀丽 邓兵
第1页

    参见附件。

     [2] 陈旺军.急性冠脉综合征血清sCXCL16、hs-CRP水平变化及辛伐他汀的干预作用[J].浙江临床医学,2010,12(10):1077-1078.

    [3] Zhuge X,Murayama T,Arai H,et al. CXCL16 is a novel angiogenic factor for human umbilical vein endothelial cells [J]. Biochem Biophys Res Commun,2005,331(4):1295-1300.

    [4] Lehrke M,Millington SC,Lefterova M,et al. CXCL16 is a marker of inflammation,atherosclerosis,and acute coronary syndromes in humans [J]. J Am Coll Cardiol,2007,49:442-449.

    [5] 王克迪,刘志忠,王瑞珉,等.CXCL16基因多态性与C反应蛋白的相关性研究[J].检验医学,2011,26(1):1-3.

    [6] 陈阳.不同冠心病血清soL-CXCL16,soL-ICAM1及hsCRP水平研究[J].实用临床医药杂志,2011,15(5):30-32.

    [7] Yi GW,Zeng T. Circulating CXCL16 is related to the severity of coronary artery stenosis [J]. Archives of Medical Research,2008,39(5):531-535.

    [8] 李定良,巫相宏.急性冠脉综合征患者趋化因子CXCL1 6与GRACE积分的相关性及临床意义[J].当代医学,2011,17(3):19-21.

    [9] Ki HH,Kyung H,Jae HP,et al. C-Reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes [J].Circulation,2004,109(21):2566-2571.

    [10] Stoneman VE,Bennett MR. Role of apoptosis in atherosclerosis and its therapeutic implications [J]. Clin Sci,2004,107(4):343-354.

    [11] Aslanian AM,Charo IF. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis [J]. Circulation,2006,114(6):583-590.

    (收稿日期:2012-07-26 本文编辑:郝明明)

    

您现在查看是摘要介绍页,详见PDF附件(2895kb)